CERO CONCERO INC
$0.01
CONCERO INC (CERO) is expected to report earnings on November 13, 2026, during market hours.
CONCERO INC Reported Earnings
Friday, August 14, 2026 · 12:00 AM ET
Earnings Date
Nov 13
Friday · 5:20 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
-
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About CONCERO INC
CERo Therapeutics Holdings Inc. is an immunotherapy company advancing the development of next generation engineered T cell therapeutics for the treatment of cancer. The company's lead product candidate includes CER-1236. CERo Therapeutics Holdings Inc., formerly known as Phoenix Biotech Acquisition Corp., is based in OAKLAND, Calif.
Industry
Business Software and Services
Charts powered in part by Lightweight Charts™ by TradingView.